SCHEMBL20097950

SCHEMBL20097950

Nc1cc(Cl)c(Cl)c(S(=O)(=O)c2c(O)c(Cl)cc(Cl)c2Cl)c1O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD17B10 Q99714 7/20 0.43
▸ HPGD P15428 5/20 0.43
▸ TSHR P16473 5/20 0.43
▸ MAPK1 P28482 2/20 0.43
▸ CASP1 P29466 2/20 0.41
▸ THRB P10828 3/20 0.39
▸ CYP3A4 P08684 5/20 0.38
▸ RECQL P46063 3/20 0.38
▸ ALOX15 P16050 3/20 0.38
▸ MAPT P10636 2/20 0.38
▸ MEN1 O00255 2/20 0.38
▸ HTT P42858 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ HSPA5 P11021 2/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ USP2 O75604 1/20 0.38
▸ EGFR P00533 1/20 0.38
▸ LMNA P02545 1/20 0.38
▸ ESR1 P03372 1/20 0.38
▸ ERBB2 P04626 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30197915 0.90 HSD17B10 (0.52) HSD17B10HPGDTSHRMAPK1CASP1
SCHEMBL14234676 0.90 HSD17B10 (0.52) HSD17B10HPGDTSHRMAPK1CASP1
SCHEMBL14769312 0.80 SIRT1 (0.46) HSD17B10HPGDTSHRMAPK1CASP1
SCHEMBL31046816 0.76 TSHR (0.41) HSD17B10HPGDTSHRMAPK1CASP1
SCHEMBL16233577 0.75 CYP3A4 (0.47) HSD17B10HPGDTSHRMAPK1CASP1
SCHEMBL11155205 0.71 HSD17B10 (0.59) HSD17B10HPGDTSHRMAPK1CASP1
SCHEMBL11055181 0.69 ALDH1A1 (0.41) HSD17B10HPGDTSHRMAPK1CASP1
SCHEMBL29433374 0.69 HSD17B10 (0.44) HSD17B10HPGDTSHRMAPK1CASP1
SCHEMBL2811005 0.68 GAA (0.50) HSD17B10HPGDTSHRCASP1THRB
SCHEMBL11655514 0.68 ACLY (0.49) HSD17B10HPGDTSHRMAPK1CASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9957484-B2 Methods for promoting cell reprogramming SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE (US) 2018-05-01 — — US disclosed
Send feedback